Investor
Advancing dermatology through strategic acquisitions and global partnerships for innovative therapies.
Ballerup
Who they are
LEO Pharma is a global pharmaceutical company with over 115 years of heritage, dedicated to advancing medical dermatology. While primarily a pharmaceutical developer and manufacturer, LEO Pharma also acts as a strategic investor. Their investment activities focus on acquisitions and licensing deals to expand their pipeline and strengthen their global leadership in dermatology. They seek innovative, late-stage assets and companies that complement their existing portfolio, rather than engaging in early-stage venture capital.
What they invest in
Where to find them
Loading nearby…